bullish
Takeda Pharmaceuticals - Initiating Coverage - In Pursuit of Growth Drivers
158 Views06 Feb 2017 15:56
We initiate coverage on Takeda Pharmaceutical with a neutral rating and a DCF based target price of ¥ 5,200. We expect the Entyvio, Ninlaro and...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 24-minute read)
Discussions
(Paid Plans Only)
x